OTCMKTS:LCDX - Lucid Stock Price, Forecast & News Adding Choose a watchlist: Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding Lucid Inc Please log in to your account or sign up in order to add this asset to your watchlist. Log In and Add $0.50 +0.01 (+2.06 %) (As of 03/31/2020 03:35 AM ET) Add Compare Today's Range$0.45Now: $0.50▼$0.5550-Day Range$0.50MA: $0.78▼$0.9852-Week Range$0.25Now: $0.50▼$1.10Volume6,266 shsAverage Volume20,573 shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/ABetaN/A ProfileAdvanced ChartInsider TradesHeadlinesSocial Media Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email Caliber Imaging & Diagnostics, Inc., a medical technologies company, designs, develops, and markets imaging solutions that shows tissue at the cellular level in the United States. The company provides VivaScope 1500, a reflectance confocal imaging system that enables clinicians and researchers to capture confocal images that depict cellular structures of living tissue; and VivaScope 3000, a hand-held in vivo reflectance confocal microscope for skin imaging. It also offers VivaScan software to schedule patients for examinations, perform imaging examinations on one or more lesions during a visit, review, and report on images obtained during an examination, as well as VivaNet, a digital telepathology system. The company was formerly known as Lucid, Inc. and changed its name to Caliber Imaging & Diagnostics, Inc. in August 2012. Caliber Imaging & Diagnostics, Inc. was founded in 1991 and is headquartered in Andover, Massachusetts.Read More Industry, Sector and Symbol Stock Exchange OTCMKTS Industry Medical Appliances & Equipment Sub-IndustryN/A SectorMedical Current SymbolOTCMKTS:LCDX Previous Symbol CUSIPN/A CIKN/A Webhttp://www.caliberid.com/ Phone+1-585-2399800Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/APrice-To-Earnings Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AProfitability EPS (Most Recent Fiscal Year)N/A Net IncomeN/A Net MarginsN/A Return on EquityN/A Return on AssetsN/AMiscellaneous Employees28 Outstanding SharesN/AMarket CapN/A Next Earnings DateN/A OptionableNot Optionable Receive LCDX News and Ratings via Email Sign-up to receive the latest news and ratings for LCDX and its competitors with MarketBeat's FREE daily newsletter. OTC:LCDX Rates by TradingView Lucid (OTCMKTS:LCDX) Frequently Asked Questions How has Lucid's stock been impacted by COVID-19 (Coronavirus)? Lucid's stock was trading at $0.73 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization. Since then, LCDX stock has decreased by 32.2% and is now trading at $0.4950. View which stocks have been mosted impacted by Coronavirus. Has Lucid been receiving favorable news coverage? Media stories about LCDX stock have been trending somewhat negative this week, according to InfoTrie. The research firm identifies negative and positive news coverage by reviewing more than six thousand blog and news sources in real time. The firm ranks coverage of publicly-traded companies on a scale of negative five to five, with scores nearest to five being the most favorable. Lucid earned a media sentiment score of -1.4 on InfoTrie's scale. They also assigned headlines about the company a news buzz of 0.0 out of 10, meaning that recent news coverage is extremely unlikely to have an effect on the stock's share price in the next few days. View the latest news aboutLucid. Who are some of Lucid's key competitors? Some companies that are related to Lucid include Smith & Nephew (SN), Corindus Vascular Robotics (CVRS), Consort Medical (CSRT), Ekf Diagnostics (EKF), Immunodiagnostic Systems (IDH), Theralase Technologies (TLT), LiDCO Group (LID), Intelligent Ultrasound Group (MED), Deltex Medical Group (DEMG), InspireMD (NSPR), Zecotek Photonics (ZMS), MCP Income Opp Trust Ordinary Units FP (MOT) and Verisante Technology (VRS). What other stocks do shareholders of Lucid own? Based on aggregate information from My MarketBeat watchlists, some companies that other Lucid investors own include Etsy (ETSY), J C Penney (JCP), Benefitfocus (BNFT), Baidu (BIDU), BioTelemetry (BEAT), Activision Blizzard (ATVI), Amgen (AMGN), Advanced Micro Devices (AMD), Akers Biosciences (AKER) and AdvisorShares Vice ETF (ACT). Who are Lucid's key executives? Lucid's management team includes the following people: Mr. William J. Shea, Exec. Chairman (Age 71)Mr. L. Michael Hone, CEO & Director (Age 69)Mr. William J. Fox, CTO & VP of Technology Operations (Age 53)Ms. Karen Howe, Chief Financial OfficerMr. Robert T. Kelley, VP of Sales and Marketing What is Lucid's stock symbol? Lucid trades on the OTCMKTS under the ticker symbol "LCDX." How do I buy shares of Lucid? Shares of LCDX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. What is Lucid's stock price today? One share of LCDX stock can currently be purchased for approximately $0.50. What is Lucid's official website? The official website for Lucid is http://www.caliberid.com/. How can I contact Lucid? Lucid's mailing address is 100 Burtt Rd Ste 203, ANDOVER, MA 01810-5920, United States. The company can be reached via phone at +1-585-2399800. MarketBeat Community Rating for Lucid (OTCMKTS LCDX)Community Ranking: 2.5 out of 5 ( )Outperform Votes: 90 (Vote Outperform)Underperform Votes: 89 (Vote Underperform)Total Votes: 179MarketBeat's community ratings are surveys of what our community members think about Lucid and other stocks. Vote "Outperform" if you believe LCDX will outperform the S&P 500 over the long term. Vote "Underperform" if you believe LCDX will underperform the S&P 500 over the long term. You may vote once every thirty days. This page was last updated on 3/31/2020 by MarketBeat.com StaffFeatured Article: Pattern Day Trader - What is the PDT Rule?
